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ABSTRACT
MEYER, J. D., K. M. CROMBIE, D. B. COOK, C. J. HILLARD, and K. F. KOLTYN. Serum Endocannabinoid and Mood Changes after
Exercise in Major Depressive Disorder.Med. Sci. Sports Exerc., Vol. 51, No. 9, pp. 1909–1917, 2019. The endocannabinoid (eCB) system is
implicated in the pathophysiology of depression and is responsive to acute exercise in healthy adults. Purpose:We aimed to describe acute
changes in serum eCB across a prescribed moderate (MOD) and a self-selected/preferred (PREF) intensity exercise session in women with
major depressive disorder (MDD) and determine relationships between changes in eCB and mood states. Methods: Women with MDD
(n = 17) exercised in separate sessions for 20 min on a cycle ergometer at both MOD or PREF in a within-subjects design. Blood was drawn
before and within 10 min after exercise. Serum concentrations of eCB (anandamide [AEA], 2-arachidonoylglycerol) and related lipids
(palmitoylethanolamine, oleoylethanolamine, 2-oleoylglycerol) were quantified using stable isotope-dilution, liquid chromatography/mass
spectrometry/mass spectrometry. The profile of mood states and state-trait anxiety inventory (state only) were completed before, 10 min
and 30 min postexercise. Results: Significant elevations in AEA (P = 0.013) and oleoylethanolamine (P = 0.024) occurred for MOD (mod-
erate effect sizes: Cohen’s d = 0.58 and 0.41, respectively). Significant (P < 0.05) moderate negative associations existed between changes in
AEA and mood states for MOD at 10 min (depression, confusion, fatigue, total mood disturbance [TMD] and state anxiety) and 30 min post-
exercise (confusion, TMD and state anxiety). Significant (P < 0.05) moderate negative associations existed between 2-arachidonoylglycerol
and mood states at 10 min (depression and confusion) and 30 min postexercise (confusion and TMD). Changes in eCB or related lipids or
eCB–mood relationships were not found for PREF. Conclusion: Given the broad, moderate–strength relationships between improve-
ments in mood states and eCB increases after MOD, it is plausible that the eCB system contributes to the mood-enhancing effects of
prescribed acute exercise in MDD. Alternative mechanisms are likely involved in the positive mood state effects of preferred exercise.
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Major depressive disorder (MDD) is a heterogeneousillness affecting roughly 3 in 10 people during theirlifetime (1) with no identified single cause or spe-
cific biological abnormality that fully explains this pervasive
disease. Exercising can improve mood states and well-being
in healthy adults and in patients with MDD (2–4). Indeed, ex-
ercise training is an effective treatment for MDD (5) and ap-
pears to be as effective at treating depression as antidepressant
medications and other accepted behavioral therapies (6–8). In
addition to exercise’s chronic effects, a single session of exer-
cise improves various mood states for minutes to hours in
healthy adults (9–11) and in those suffering from MDD (12).
However, the mechanisms by which exercise influences mood
acutely or chronically are not well understood. As a result, exer-
cise training trials inMDD are designed and powered based pri-
marily on the probability of a significant mood or other clinical
response. Given the heterogeneity and variability of depressed
mood in MDD, it is plausible that treatment efficacy would be
better realized if exercise interventions were designed to opti-
mize engagement of the biological mechanisms that underlie
exercise’s mood effects. The most well-known hypothesized
mechanism that exercise improves mood states through release
of endorphins has limited scientific support (13). Although ex-
ercise’s anti-inflammatory effects, influences on neurotransmit-
ters and on neurotrophins have all been hypothesized to be
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involved in the mental health effects of exercise (14–17),
limited evidence from humans evaluates the hypothesized
mechanistic relationships between potential factors and the
psychological effects of both acute and chronic exercise. There-
fore, there is a need to continue to explore the potential mecha-
nisms underlying the mood effects of exercise, particularly in
populations suffering from mood disorders where exercise
may be the most influential (18).
One system that has been implicated in the pathophysiol-
ogy of MDD is the endocannabinoid (eCB) system (19,20).
The two main eCB, 2-arachidonoylglycerol (2-AG) and
N-arachidonoylethanolamide (anandamide [AEA]) bind to
the two major cannabinoid receptors (CB1 and CB2), which
are found throughout the central and peripheral nervous sys-
tems. Previous reports suggest circulating eCB concentrations
are lower in depressed patients than healthy adults (21,22). In
addition, a genetic polymorphism in the CB1 receptor gene
has been associated with an increased risk of antidepressant
treatment resistance in depressed patients (23). Therefore, as-
sessments of circulating eCB in MDD in relation to mood
states may be informative for further understanding the dis-
ease pathology and treatment.
Exercise increases circulating concentrations of eCB and
there is emerging support for a relationship between exercise-
induced changes in circulating eCB and acute exercise-
induced improvements in mood states. For example, Raichlen
et al. (24) reported that exercise-induced increases in circulat-
ing eCB were associated with increases in positive affect in a
sample of recreationally fit adults. Brellenthin et al. (25) found
significant relationships between exercise-induced alterations
in circulating eCB and improvements in mood states (i.e., de-
creases in feelings of depression, tension, and total mood dis-
turbance and increases in feelings of vigor) in healthy adults
with varying levels of physical activity after both preferred
and prescribed moderate-intensity aerobic exercise. Further,
Crombie et al. (26) reported that greater increases in circulat-
ing 2-AG were associated with decreases in negative affect af-
ter moderate aerobic exercise in adults with posttraumatic
stress disorder (PTSD). It has yet to be determined what effect,
if any, exercise has on circulating eCB in MDD and what role
circulating eCB may play in the mood-enhancing effects of
acute exercise. In addition, past research has examined relatively
short-duration mood effects of exercise (10 m or less) and further
assessments would be useful to determine the potential extent of
the effects of eCB on variation in mood states after exercise.
Past research has found significant associations between
exercise-induced eCB changes and exercise-induced mood
state changes after both preferred intensity and duration (25)
and moderate-intensity aerobic exercise (26) across various
mood states in healthy and PTSD populations. Considering
past eCB and exercise research, and the mood-enhancing po-
tential of exercise in MDD (18,27), the present research sought
to compare mood state and eCB responses to moderate and
preferred-intensity aerobic exercise inMDD. Therefore, the pres-
ent investigation pursued two primary research questions. First,
in adults with MDD, does acute exercise alter serum levels of
eCB (AEA and 2-AG) and related lipids (palmitoylethanolamine
[PEA], oleoylethanolamine [OEA], and 2-oleoylglycerol [2-OG])
in response to moderate and preferred-intensity exercise? Second,
are exercise-induced changes in mood states associated with
exercise-induced changes in serum eCB in adults with MDD
after moderate and preferred-intensity exercise?
MATERIALS AND METHODS
The present analysis details the eCB response to two acute
exercise sessions in female participants with MDD. The sam-
ples used in these secondary analyses were stored samples
from a larger study (n = 24) that evaluated the effect of acute
exercise intensity on depressed mood (12), biological markers
related to depression/exercise (28), and exercise intensity
preferences (29). The larger study included five visits exam-
ining single sessions of quiet rest, or light-, moderate-, or
hard-intensity exercise or a preferred-intensity exercise ses-
sion that were completed by each participant in a randomized
and counterbalanced order with visits at least 1 wk apart from
each other. Only serum samples from the moderate and pre-
ferred exertion sessions were assessed for eCB content. The
information below details the events of those two visits, com-
plete project details are reported elsewhere (12,28,29). All
procedures were approved by the local institutional review
board at the University of Wisconsin-Madison and written
informed consent was obtained from each participant. The
described work was carried out in accordance with the Dec-
laration of Helsinki. Samples for the present analysis come
from the (a) moderate-intensity exercise session and (b) the
preferred exertion session, and only from participants whose
preexercise profile of mood states (POMS) depression scores
were above published norms (i.e., 4+ (30)) for both sessions,
and for whom preexercise and postexercise samples existed
for both sessions (n = 17). As some of the participants from
the larger study reported zero or low values for feelings of de-
pressed mood preexercise for these sessions (i.e., no to mini-
mal depressed mood), we did not include those participants
due to our interest in evaluating eCB and mood relationships.
Participants
Details regarding methods, participants and exercise ses-
sions are published elsewhere (12,28,29) and only information
pertinent to the present analyses are reported here. Participants
were recruited from the University of Wisconsin-Madison
campus and surrounding areas. Interested potential partici-
pants underwent a phone screen to assess possible eligibility.
Those who appeared eligible after the phone screen were in-
vited to the laboratory for the first day of testing. Participants
were females, age 20 to 60 yr, who self-reported a current di-
agnosis of MDD, were deemed safe to exercise based on the
Physical Activity Readiness Questionnaire (31) and were not
currently undergoing psychiatric treatment (counseling or
medication) or were on a stable regimen for the 8 wk preced-
ing their initial visit. Self-reported current diagnosis of MDD
was confirmed via the Mini International Neuropsychiatric
http://www.acsm-msse.org1910 Official Journal of the American College of Sports Medicine
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Interview (32) on each participant’s first visit. Participants tak-
ing stable doses of antidepressant medications were included if
they currently met criteria for MDD and if they did not change
their medication regimen during the course of the study. Partici-
pants were excluded if they self-reported being pregnant, a current
smoker, currently taking opioid or analgesic medications, or abus-
ing alcohol or other illegal drugs (including cannabis). Participants
were compensated US $20 at the end of each study visit.
Procedures
Participants reported to the research laboratory on 2 d, sep-
arated by at least 1 wk. Participants first completed baseline
questionnaires and then completed one of the two exercise ses-
sions. Each session in the current analysis included 30 min of
exercise, either 1) at a moderate intensity or 2) at a preferred
intensity, without intensity prescription (i.e., a session where
participants could change their workload freely and without
restrictions). After the exercise session, participants filled out
questionnaires at 10 and 30 min postexercise. Blood was
drawn via standard venipuncture into serum tubes from the
antecubital vein after completing baseline questionnaires
(pre) and as quickly as possible after the session ended (from
the opposite arm), always within 10 min (post). Each partici-
pant’s sessions were scheduled at the same time of day, with
sessions lasting approximately 2 h. All sessions were per-
formed on an electronically braked cycle ergometer (Lode
Corival, Lode BV, Groningen, The Netherlands). Ventilation,
oxygen consumption (V̇O2), carbon dioxide production
(V̇CO2) and work rate were obtained continuously and ana-
lyzed with 15-s averaging using a metabolic cart (TrueOne,
ParvoMedics, Sandy, UT) and two-way non-rebreathing
valve (Hand-Rudolph, Kansas City, MO) which allowed
for metabolic equivalent estimation (METs). Respiratory ex-
change ratio was calculated as the ratio of V̇CO2 to V̇O2. Multi-
ple comparisons to a 3-L syringe were performed each test for gas
analyzer calibration. A Polar heart rate monitor (Polar, Lake Suc-
cess, NY) was used to record heart rate throughout each session.
Exercise sessions. Exercise sessions and monitoring are
detailed elsewhere (12). Briefly, exercise was performed on a
stationary bicycle with ratings of perceived exertion (RPE),
using Borg’s 6 to 20 rating scale (33), used both to prescribe
the intensity of the exercise for the moderate session and to
evaluate exertion during both moderate and preferred sessions.
Before the first session, participants were provided with stan-
dardized RPE instructions according to the manual (33). Par-
ticipants self-reported their RPE every 5 min during exercise.
For the moderate-intensity exercise session, participants were
instructed to maintain a moderate intensity, which corresponds
to a RPE of “13” with a verbal anchor of ‘somewhat hard.’
Workload adjustments were encouraged as necessary to main-
tain the prescribed intensity (i.e., if a participant self-reported a
“12” RPE during the moderate session, they were encouraged
to manipulate the resistance on the bicycle to achieve a “13”).
For the preferred intensity condition (as detailed in (29)),
participants were instructed to choose any intensity of exercise
at which they would prefer to exercise with freedom to manip-
ulate the intensity throughout. The rest of the exercise instruc-
tions were identical to those given in the prescribed session
with the sole difference being the lack of an intensity prescrip-
tion (instructional sets for the two sessions are in Supplemen-
tal Digital Content 1 in (29)).
During the entirety of both sessions, the RPE scale was
affixed to the wall in front of the participant to allow partici-
pants to self-monitor their exertion throughout the 20 min
of exercise. Participants were instructed to maintain 60 to
70 rpm and adjust the resistance to maintain the intensity in-
structions for each session. Over the 5-min warm-up, partici-
pants increased their exertion to achieve the session’s
intensity at the end of the 5-min period (i.e., either end the
5 min at a moderate intensity or, in the preferred condition,
whatever intensity they would like to begin with). Participants
then exercised for 20 min according to the session’s instruc-
tions before ending with a 5-min cool-down.
Self-report measures. Participants completed the Beck
Depression Inventory-II (BDI; (34)), the 65-item POMS (35)
and the 20 state items from the State-Trait Anxiety Inventory
(STAI; (36)) at baseline and then completed the POMS and
STAI at 10 min and 30 min postexercise. The primary out-
comes for the changes in mood states across exercise were
the original six POMS subscales (depression, tension, confu-
sion, fatigue, vigor, and anger), the total mood disturbance
(TMD) score from the POMS and state anxiety. The POMS
subscales have been shown to have internal consistency rang-
ing from 0.63 to 0.96 (37) (although the psychometric proper-
ties of the confusion subscale have been questioned (38,39)).
In addition, the STAI also has high internal consistency rang-
ing from 0.86 to 0.95. Mood states and state anxiety when
measured via the POMS and, respectively, are responsive to
acute exercise when used with “right now” instructions (used
in the present study) and these measures have been widely
used to measure exercise’s acute mood effects (9).
Sample collection and processing.Blood was allowed
to clot for 15 min at room temperature and then centrifuged at
−4°C for 10 min. Serum was then separated and immediately
stored at −80°C until further processing took place. ECB extrac-
tions and sample processing was performed by the same indi-
vidual and all samples were prepared within the same week
(see (26) for step-by-step eCB extractions and sample process-
ing procedures). After preparation, the concentrations of eCB
(AEA and 2-AG), along with related biogenic lipids (PEA,
OEA, 2-OG) were quantified using stable isotope-dilution,
electrospray ionization liquid chromatography/mass spec-
trometry of the daughter ions (LC-ESI-MS-MS) as previously
described (26). Analysis of all samples by mass spectrometry
was conducted within 1 wk of processing and each partici-
pant’s samples were run together.
Data Analysis
All analyses were conducted with SPSS version 23.0 for
Windows (IBM Corporation, Armonk NY). There were no
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missing data for any outcomes. Univariate repeated-measures
ANOVA for each of the subscores and total scores from the
POMS and STAI were performed to assess changes in
mood states across time. Dependent-samples t-tests com-
pared exercise-related variables between sessions. To meet
the normality assumption (i.e., Shapiro–Wilk test) for para-
metric tests, lipid concentrations were logarithmically trans-
formed (log10) before conducting parametric statistical analyses.
Presession self-report measures, exercise variables and se-
rum content of eCB and related lipids were compared be-
tween the sessions with paired-samples t-tests. Due to the
secondary nature of these analyses, alpha was set at 0.05
for each statistical test.
Question I. Paired-sample t-tests were conducted compar-
ing presession to postsession values for each of the circulating
eCB and related lipids (i.e., AEA, 2-AG and PEA, OEA,
2-OG) for each session. Cohen’s d (40) effect sizes along with
95% confidence intervals (41) were used to quantify the magni-
tude of changes presession to postsession. Effect sizes were con-
sidered to be small (0.20–0.49), moderate (0.50–0.79) or large
(>0.80) based upon Cohen’s cautious recommendations (40).
Question II.Due to the small cell size for each mood state-
eCB correlation, nonparametric testing using Spearman’s ρ
correlations assessed relationships betweenpresession to postsession
changes in circulating eCB and changes in mood states and
state anxiety. Values of ρ < 0.4 were considered weak, between
0.4 and 0.7 to be moderate and greater than 0.7 to be strong.
RESULTS
Participant characteristics and exercise sessions.
Participants were adult females (n = 17, age: 40.8 ± 14.8 yr old;
mean ± SD) with a mean body mass index of 31.2 ± 8.5 kg·m2
with 9 of 17 taking at least one antidepressant medication.
Means and SD are presented in Table 1 for self-report mea-
sures. Participants self-reported having mild-to-moderate de-
pression over the past 2 wk upon arrival for each session
(BDI), with significantly lower depressive symptoms for the
preferred session than for the moderate session (P = 0.028).
Participants also reported significantly lower state anxiety
for the preferred session (P = 0.017). On average, each sub-
scale of the POMS as well as TMD improved across both
exercise sessions (Table 1). Vigor increased while each other
subscale, TMD and state anxiety decreased from baseline to
both 10 min and 30 min postsession. Univariate repeated-
measures ANOVA for each of the subscores and total scores
from the POMS and STAI (P < 0.05) demonstrated significant
improvements in all measures across time, with the exception
of the STAI and anger which did not significantly improve in
the preferred session only.
Exercise sessions resulted in similar mean responses to the
exercise stimuli across the sessions (allP > 0.05; Table 2). Par-
ticipants selected a range of exercise intensities in the preferred
condition (Fig. 1), although sessions were not significantly dif-
ferent from each other on average.
Effects of exercise sessions on eCB and related
lipids. There were no baseline differences between sessions
for any of the eCB or related lipids (paired-samples t-tests;
all P > 0.05). Changes in eCB and related lipids across exer-
cise are presented in Table 3. In the moderate session, a signif-
icant increase from preexercise to postexercise was found for
AEA (t (16) = −2.802, P < 0.05) and OEA (t (16) = −2.487,
P < 0.05), whereas no significant differences were found for
2-AG (t (16) = 1.695), P > 0.05), PEA (t (16) = −0.006,
P > 0.05), or 2-OG (t (16) = 1.747, P > 0.05). For the pre-
ferred session, no significant differences were found for AEA
(t (16) = −0.963, P > 0.05), 2-AG (t (16) = 1.739, P > 0.05),
OEA (t (16) = −0.605, P > 0.05), PEA (t (16) = 1.804,
P > 0.05), and 2-OG (t (16) = 1.396, P > 0.05). Cohen’s d ef-
fect sizes representing the magnitude of changes in eCB and
related lipids after the moderate and preferred exercise ses-
sions are illustrated in Figure 2. In addition, effect sizes for
changes in eCB and related lipids across the exercise sessions
based on antidepressant usage are found in Supplemental
TABLE 1. Baseline symptoms and mood across the exercise sessions.
Moderate Session (n = 17) Preferred Session (n = 17)
Measure Sample Range Baseline 10 min 30 min Time, P Baseline 10 min 30 min Time, P
Beck Depression Inventory-II 24.1 (9.4)* 18.5 (9.6)*
POMS
Total mood disturbance 76–224 149.2 (27.2) 123.6 (18.0) 119.4 (24.7) <0.001 141.2 (31.7) 122.1 (26.9) 122.6 (28.2) <0.001
Tension 1–22 10.3 (4.0) 6.6 (2.9) 5.0 (2.7) <0.001 9.6 (4.6) 6.1 (4.4) 6.5 (3.9) <0.001
Depression 0–44 19.2 (10.8) 11.0 (8.0) 9.6 (9.0) <0.001 14.8 (8.8) 10.9 (7.4) 10.9 (7.7) 0.002
Anger 0–32 5.4 (8.5) 2.9 (5.2) 2.5 (4.9) 0.003 6.3 (9.1) 3.3 (5.2) 2.9 (5.1) 0.057
Vigor 0–28 6.6 (5.1) 10.0 (3.7) 10.2 (6.0) <0.001 7.2 (5.1) 11.1 (6.4) 9.8 (7.4) 0.004
Fatigue 0–26 11.9 (7.4) 6.9 (4.1) 6.6 (6.0) <0.001 9.8 (7.1) 6.8 (6.4) 6.5 (5.9) <0.001
Confusion 0–19 8.9 (3.9) 6.2 (3.3) 5.8 (4.2) <0.001 8.0 (5.1) 6.1 (4.1) 5.6 (4.4) 0.004
State anxiety inventory 22–67 50.9 (9.3)* 42.0 (8.0) 40.9 (9.9) <0.001 46.2 (9.6)* 43.2 (10.3) 40.6 (14.2) 0.212
Values represent mean (SD) unless otherwise noted. Values in sample range indicate the distribution of each outcome across all time points. Time P value represents ANOVA results for within-
subject change across time.
*P < 0.05 for between-session difference at baseline via paired-sample t-test.
TABLE 2. Exercise data summary for both sessions.
Moderate Preferred
Mean SD Mean SD
RPE 13.1 0.18 12.7 1.9
HR (bpm) 126.7 20.8 131.1 28.7
Energy expenditure (METs) 4.0 1.6 4.2 1.7
RER 0.95 0.05 0.95 0.04
Power (W) 72.5 33.5 72.5 38
Participants self-selected exercise intensity and could manipulate intensity throughout the
preferred session by altering resistance, while they were instructed to maintain a constant
RPE of 13 in the moderate session.
http://www.acsm-msse.org1912 Official Journal of the American College of Sports Medicine
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Digital Content 1 (see Table, Supplemental Digital Content 1,
Log eCB and related lipid changes based on antidepressant us-
age, http://links.lww.com/MSS/B582).
Relationships between changes in eCB and mood
states. Spearman ρ correlation coefficients were calculated
to examine the relationship between the percent change (pre
to post) in eCB within 10 min postexercise and the change
in mood states at 10 and 30 min after both the moderate and
preferred sessions (Table 4).
At 10 min after the moderate session, significant small-
to-moderate negative correlations were found between the
change in AEA and the change in feelings of depression, con-
fusion, fatigue, TMD and state anxiety. Additionally, signifi-
cant moderate negative correlations were found between the
change in 2-AG across the exercise and the change in depres-
sion and confusion.
At 30 min after the moderate session, significant moderate
negative correlations were found between the change in
AEA across the exercise and the change in confusion, total
mood disturbance, and state anxiety. Additionally, significant
moderate negative correlations were found between the
change in 2-AG across the exercise and the change in confu-
sion and total mood disturbance.
In contrast to the moderate session, there were no significant
correlations between the change in eCB and the change in
mood states at 10 or 30 min postexercise for the preferred-
intensity session.
DISCUSSION
The present results show that moderate but not preferred-
intensity exercise resulted in increases in circulating levels of
one eCB (AEA) and a related lipid (OEA) in women with
MDD (Fig. 2). Further, changes in AEA after the moderate
session were broadly related to exercise-related changes in
feelings of depression, confusion, fatigue, total mood distur-
bance and state anxiety while changes in 2-AG were also sig-
nificantly associated with changes in feelings of depressed
mood, confusion and total mood disturbance up to 30 min
postsession (Table 4). Significant overall changes in circulat-
ing eCB and related lipids did not occur across the preferred
session (all d ≤ 0.40) and changes in mood states were not sig-
nificantly related to changes in eCB for this session. Taken to-
gether, these results partially corroborate and extend previous
findings of associations between exercise-induced changes in
mood states and in circulating eCB after aerobic exercise in
men and women with varying physical activity levels (25)
and in adults with PTSD (26) to a clinically depressed female
sample. The present results also extend this previous work to
show that longer-durationmood changes at 10 and 30min post-
exercise were weakly-to-moderately correlated to the changes
in eCB within 10 min postmoderate exercise (absolute value
of rho = 0.25 to 0.67). This represents a longer timeframe al-
though a similar magnitude of association in comparison to
previous work. The continuity of many of the eCB–mood re-
lationships at both 10 and 30 min post–moderate-intensity ex-
ercise suggests that during-exercise eCB alterations may have
longer-term (i.e., 30 min or longer) associations with fluctua-
tions in mood states.
FIGURE 1—Rating of perceived exertion for each participant across 20 min of exercise in preferred (A) and moderate (B) sessions. Each line represents a
single participant’s self-reported rating of perceived exertion recorded at 5-min intervals across each bout. Participants could change their exertion as they
desired across the preferred session (A) while they were instructed to maintain a rating of perceived exertion of 13 in the moderate session (B).
TABLE 3. Changes in serum eCB and related lipid (log10 values) after moderate- and
preferred-intensity exercise.
Moderate Session Preferred Session
Pre Post Pre Post
Mean SD Mean SD P Mean SD Mean SD P
AEA 0.18 0.16 0.27 0.14 0.013* 0.24 0.14 0.27 0.13 0.350
2-AG 1.71 0.26 1.63 0.24 0.109 1.72 0.23 1.65 0.21 0.101
OEA 0.87 0.16 0.94 0.15 0.024* 0.92 0.16 0.94 0.16 0.554
PEA 0.21 0.23 0.21 0.18 0.996 0.23 0.11 0.18 0.12 0.090
2-OG 3.14 0.26 3.09 0.31 0.100 3.11 0.26 3.06 0.25 0.182
Units are pmol·mL−1. P values are from paired-samples t-tests comparing preexercise to
postexercise.
*Significance at P < 0.05.
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There is a growing appreciation for the influence of exercise
on eCB and their potential role in exercise-related changes in
mood states and affect (42). Raichlen and colleagues (24) hy-
pothesized that the “runner’s high” (defined by Raichlen et al.
as neurobiological rewards during or postexercise) may be due
to eCB release during exercise, and found that increases in
AEA postexercise were positively associated with increases
in positive affect after exercise. Their additional research (43)
suggested a potential intensity dependence of AEA changes
across exercise in regular runners whereby moderate-intensity
exercise yielded increases in circulating AEA, but very low
and very high intensity did not. Heyman and colleagues (44)
found that AEA did not increase after 60 min cycling at 55%
of maximal power output, although AEA did increase after a
subsequent time trial corresponding to an amount of work equal
to 30 min at 75% of maximal power output and was still ele-
vated at 15 min postexercise in trained cyclists. Our findings
also indicate an increase in AEA after moderate exercise
supporting the past findings of elevated serum AEA after
moderate-intensity exercise.
Reports of the effects of exercise on circulating 2-AG con-
centrations have been less consistent. The early research in this
area had not found significant elevations in 2-AG after exer-
cise (43–46), but more recent research with larger sample sizes
have reported elevations in 2-AG after exercise (25,26,47),
and weak-to-moderate correlations between changes in 2-AG
and improvements in mood. For example, Brellenthin et al.
(25) found increases in AEA and 2-AG after moderate- and
preferred-intensity treadmill exercise in healthy college-age
men and women, which were associated with improvements
in mood states, including depression, tension, total mood dis-
turbance and vigor. After moderate aerobic exercise in adults
with PTSD, Crombie et al. (26) found a negative correlation
between the change in negative affect and 2-AG concentra-
tions, indicating greater reductions in negative affect for indi-
viduals with a greater increase in 2-AG. Additionally, the
FIGURE 2—Cohen’s d effect sizes for the raw change in serum eCB and related lipids preexercise to postexercise in the moderate and preferred exercise
sessions with 95% confidence intervals.
TABLE 4. Moderate and preferred session relationships between changes in serum eCB and changes in mood.
Moderate Session
Depression Tension Confusion Fatigue Anger Vigor TMD State Anxiety
AEA 10 min ρ −0.562* −0.026 −0.672* −0.557* −0.345 0.257 −0.530* −0.585*
P 0.019* 0.921 0.003* 0.020* 0.176 0.320 0.029* 0.014*
30 min ρ −0.388 −0.449 −0.571* −0.348 −0.446 0.058 −0.483* −0.575*
P 0.123 0.071 0.017* 0.171 0.072 0.825 0.050* 0.016*
2-AG 10 min ρ −0.517* 0.054 −0.645* −0.322 −0.029 0.415 −0.385 −0.080
P 0.034* 0.835 0.005* 0.207 0.913 0.098 0.127 0.761
30 min ρ −0.474 −0.371 −0.604* −0.350 −0.185 0.350 −0.560* −0.356
P 0.054 0.143 0.010* 0.169 0.478 0.169 0.019* 0.160
Preferred Session
Depression Tension Confusion Fatigue Anger Vigor TMD State Anxiety
AEA 10 min ρ −0.165 −0.274 −0.344 −0.190 0.103 0.137 −0.246 −0.157
P 0.528 0.288 0.177 0.465 0.694 0.600 0.340 0.547
30 min ρ −0.114 −0.311 −0.222 0.123 0.055 0.322 −0.218 −0.092
P 0.662 0.225 0.392 0.637 0.833 0.207 0.400 0.725
2-AG 10 min ρ −0.053 0.082 0.010 0.001 0.255 0.190 0.075 −0.098
P 0.839 0.755 0.970 0.996 0.324 0.465 0.775 0.707
30 min ρ −0.089 0.011 0.037 0.083 0.198 0.139 −0.025 −0.204
P 0.735 0.966 0.887 0.751 0.446 0.594 0.926 0.433
Columns represent changes in POMS subscales from presession to postexercise at the row’s time point; ρ signifies Spearman’s rho correlation coefficient.
*Significant correlations at P < 0.05.
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magnitude of mean changes of AEA across moderate exercise
were similar to those of Crombie et al.’s PTSD sample with
both showing a roughly d = 0.50 effect size, although the pres-
ent results showed a small mean decrease in 2-AG while the
previously reported PTSD sample saw a small increase in
2-AG (d = 0.21). Overall, the consistency of mood–eCB rela-
tionships both in the present study at 10 and 30 min postexer-
cise and with recent research suggests that exercise-induced
eCB changes may be one mechanism through which exercise
improves mood states across a variety of clinical and healthy
populations.
The significant elevation (d = 0.41) of OEA in the present
study after moderate exercise is consistent with previous re-
search. Heyman and colleagues (44) found increased OEA
across and exercise bout of increasing intensity and up to
15 min postexercise. Cedernaes and colleagues (47) did not
find a significant immediate increase in OEA after cycling ex-
ercise at 75% of V̇O2 reserve, but did see an increase in OEA
4 h postexercise in young, healthy males. Finally, these results
are also consistent with those of both Brellenthin et al. (25) and
Crombie et al. (26) who found elevations in OEA after moder-
ate exercise.
Current and past research implicate a dysfunctional eCB
system in depression (19,48,49). Either genetic knockout of
components of the eCB system or pharmacological antago-
nism leads to increased depressive-like behavior in rodents
(48). In humans, depression has been linked to lower periph-
eral eCB content, with women with major depression having
lower serum 2-AG content in one report (21), whereas a sepa-
rate sample of women with major depression had reduced se-
rum 2-AG and AEA compared with healthy controls (22).
Moreover, eCB signaling can mimic many of the behavioral
and biological effects of antidepressant medications (49).
The present data further support an eCB–mood link as we
found broad relationships between acute moderate exercise-
induced changes in AEA and 2-AG with improvements in
multiple mood states in women with MDD. Together, this
demonstrates both that peripheral eCB content can be affected
by exercise in patients with MDD and suggests a role for this
system in how acute exercise improves mood state and well-
being in depression.
Preferred-intensity exercise did not lead to significant eleva-
tions in either of the eCB or any of the related lipids (Table 3)
despite similar mood changes to themoderate session (Table 1).
Moreover, changes in mood states were not significantly related
to changes in eCB (all ρ between −0.344 and 0.322; Table 4).
This may be due to specific differences between the two exer-
cise sessions. The moderate-intensity session included 20 min
of steady-state exercise whichwas instructed to be held at a con-
stant relative intensity (RPE of “13,” corresponding to a verbal
anchor of ‘somewhat hard’), with a 5-min warm-up and a 5-min
cool-down. Intensity was controlled by the participant who was
instructed to manually adjust the resistance on the bicycle to
keep their perceived exertion level at a “13.” In the preferred ex-
ertion session, participants had complete control over the resis-
tance during the 20-min between the warm-up and cool-down
and could exercise at whatever perceptual intensity they wanted
and could adjust the intensity at any time throughout the ses-
sion. The differential findings across the two sessions may be
due to the intersubject variability in how participants chose to
exercise during the preferred session (some chose to exercise
at a lower intensity while others exercised at a harder intensity;
Fig. 1) which could mask the potential effect of exercise if there
is a threshold intensity necessary to elicit exercise-induced eCB
changes (as suggested in (44)). However, this does not appear to
be the sole explanation as neither changes in AEA or 2-AG ap-
peared related to average RPE during the preferred session (Sup-
plemental Digital Content 2 and 3, http://links.lww.com/MSS/
B583 and http://links.lww.com/MSS/B584; figures depicting av-
erage RPE vs change in serum 2-AG and AEA, respectively).
Additionally, the ability to choose the intensity may have also
altered the eCB response to the exercise if this cognitive differ-
ence influenced the biological response. Finally, participants
were able to manipulate their intensity during the preferred
session rather than exercising at a steady-state intensity as in
the moderate session. Any of these differences (i.e., variable
intersubject intensity, ability to control intensity, or intra-session
intensity manipulation) may have influenced the serum eCB
changes, and further research is needed to determinewhat charac-
teristics of exercise are important for consistently eliciting an
eCB response. The presence of mood improvements in spite of
the lack of significant eCB changes in the preferred session
suggests that there are likely multiple biological mechanisms
involved in the mood-enhancing effects of exercise.
The lack of significant overall changes in eCB and related
lipids across the preferred-intensity session or relationships be-
tween exercise-induced changes in mood states and eCB are
interesting in the context of Brellenthin and colleagues’ results
(25). They found significant elevations in 2-AG and AEA and
moderate correlations between changes in mood states and
changes in eCB in response to their “preferred” exercise ses-
sion. However, the “preferred” exercise sessions in each of
these studies were considerably different. Brellenthin and col-
leagues allowed participants to manipulate both their duration
of exercise (which was fixed at 20 min in the present study)
and their intensity (similar to the present study) while running
on a treadmill (compared with a stationary bicycle in the pres-
ent study) resulting in different exercise stimuli. Additionally,
the previous study assessedmood state immediately after exer-
cise, while the present study was designed to look at slightly
longer-term mood effects (i.e., 10 and 30 min postexercise)
which may also explain the difference in findings. Finally,
the populations were different; participants in the present
study were depressed women, whereas those in the Brellenthin
et al. report were healthy young adults with either low, moder-
ate or high self-reported physical activity. Even with these differ-
ences, a significant group by time interaction in the Brellenthin
report showed that AEAwas increased to a greater extent after
their moderate session which mirrors the results in the present
sample (Fig. 2). Still, unique aspects of the population or exer-
cise stimulus (e.g., preference, intensity, duration, mode) may
be important in determining the effects of exercise sessions on
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eCB and future systematic research characterizing the eCB ef-
fects of both prescribed and preferred exercise are warranted.
Limitations. Presession differences in depressive symp-
toms betweenmoderate and preferred sessions and/or variabil-
ity in individual choices for the preferred session may have
limited statistical power to find significant relationships be-
tween eCB and changes in mood states for the preferred ses-
sion. Floor effects for mood states do not appear to have
been a major concern with the present data as each of the
POMS subscales were well above adult normative values for
each of the sessions (see (30)). Although this study evaluated
multiple mood states across time, future research would bene-
fit from understanding the duration of postexercise elevations
in eCB and how they relate to postexercise mood state and
other symptoms of depression. As this was a secondary analy-
sis, precise control of substances that could affect the eCB sys-
tem was not performed, and this will be important in future
research. Our sample of 17 women with depression with an
average BMI in the obese category was small, and the lack
of a control group or condition is a limitation, although the
sample is not uncharacteristic of a depressed population, and
the sample size is higher than, or in line with, other eCB-
exercise studies. However, given the small sample size and
number of mood states assessed without multiple comparison
adjustments, it is possible that one or more of the eCB–mood
relationships may be spurious. Nevertheless, the 12 moderate
strength associations that were significant at uncorrected
P < 0.05 between eCB changes and prescribed exercise-
induced changes in mood states (Table 4) would indicate that
larger future studies with clinical and nonclinical samples are
needed. Finally, independent verification of eCB relationships
to exercise-induced changes in mood states would strengthen
these initial findings in depression.
CONCLUSIONS
The moderate correlations between changes in mood states
after moderate-intensity exercise and changes in serum eCB
content suggest alterations in eCB signaling may be onemech-
anism through which prescribed moderate exercise improves
mood in patients with MDD. The consistency in relationships
between changes in eCB and changes in mood states at both
10 min and at 30 min postexercise extends previous reports
finding eCB–mood relationships with a single, immediate
postexercise mood state assessment in other populations.
However, exercise at a preferred intensity resulted in generally
small (all d ≤ 0.40) nonsignificant mean eCB changes even in
the presence of mood state improvements, suggesting that as-
pects of the exercise stimulus (e.g., preference, intensity, dura-
tion, mode, etc.) could be important in determining the serum
eCB response to exercise in depression. There are likely mul-
tiple mechanisms involved in the mood effects of exercise. Fu-
ture research designed to manipulate the mood response to
exercise to evaluate its influence on eCB is encouraged to bet-
ter understand this system potential related to acute exercise’s
psychological effects.
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